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The 
 
Plasmodium
 
 life cycle is a sequence of alternating invasive and replicative stages within 
the vertebrate and invertebrate hosts. How malarial parasites exit their host cells after 
completion of reproduction remains largely unsolved. Inhibitor studies indicated a role of 
 
Plasmodium
 
 cysteine proteases in merozoite release from host erythrocytes. To validate a 
vital function of malarial cysteine proteases in active parasite egress, we searched for target 
genes that can be analyzed functionally by reverse genetics. Herein, we describe a complete 
arrest of 
 
Plasmodium
 
 sporozoite egress from 
 
Anopheles
 
 midgut oocysts by targeted 
disruption of a stage-specific cysteine protease. Our findings show that sporozoites exit 
oocysts by parasite-dependent proteolysis rather than by passive oocyst rupture resulting 
from parasite growth. We provide genetic proof that malarial cysteine proteases are 
necessary for egress of invasive stages from their intracellular compartment and propose 
that similar cysteine protease–dependent mechanisms occur during egress from liver-stage 
and blood-stage schizonts.
 
Malaria is caused by intracellular parasites of the
phylum Apicomplexa that can enter and exit
host cells. The characterization of parasite and
host cell proteins involved in 
 
Plasmodium
 
 cell
entry has provided a detailed understanding of
the underlying mechanisms (1) and led to new
intervention strategies (2). In contrast, the equally
important process of 
 
Plasmodium
 
 release is less
well understood. With the exception of ooki-
netes, invasive stages (i.e., sporozoites, liver-stage
merozoites, and blood-stage merozoites) are
formed by multiple fission in processes called
sporogony and merogony, respectively. These
stages then need to egress from their intracellular
compartment and, shortly thereafter, from their
host cell. Inhibitor studies suggested that multiple
proteolytic events occur during rupture of
schizont-infected erythrocytes and subsequent
reinvasion of erythrocytes (3, 4). Treatment of
intracellular schizonts with the cysteine prote-
ase inhibitor E64 resulted in accumulation of
membrane-enclosed viable merozoites (5, 6). In
support of active proteolytic events during para-
site egress, stage-specific expression of cysteine
and serine protease activities has been detected
(7). In addition, several genes that encode po-
tential cysteine proteases have been identified
and characterized in 
 
Plasmodium
 
 (8). They in-
clude falcipain 1, a nonessential cathepsin L–like
cysteine protease with yet undefined functions
in oocyst development (9, 10), the food vacuole–
resident hemoglobinases falcipain 2/2’ and 3
(11–13), and a family of proteases that were
termed serine repeat antigens (SERAs) (14–16).
Members of this distinct 
 
Plasmodium
 
 protease
family are clustered on chromosome II (17) and
belong to papain-like cysteine proteases based
on a central 
 
 
 
30-kD protease domain. Reverse
genetics showed that some members are vital
for erythrocytic schizogony, whereas others are
dispensable for asexual growth 
 
of Plasmodium
 
(16). However, so far no function in parasite
egress has been assigned to any of these proteins.
We reasoned that inactivation of a member of
the 
 
Plasmodium
 
 papain-like cysteine protease
family for which expression is restricted to
sporogenic stages might lead to an essential
function that can be analyzed on the cellular
level. Here, we show targeted disruption of an
oocyst-specific papain-like cysteine protease in
 
P. berghei
 
. Mutant sporozoites fail to egress from
midgut oocysts. Therefore, we termed the cor-
responding protein egress cysteine protease 1
(ECP1).
 
RESULTS AND DISCUSSION
Identification of a stage-specific 
 
Plasmodium
 
 
cysteine protease
 
Several members of papain-like cysteine pro-
teases, also termed SERAs, were previously re-
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ported to be nonessential during asexual blood-stage devel-
opment (16). We tested expression of the five cysteine
proteases of the 
 
P. berghei SERA
 
 locus by RT-PCR (Fig. 1
A). Our analysis revealed that one member (
 
ECP1
 
) displayed
an interesting restriction of gene transcription to sporozoite
stages. Notably, 
 
ECP1
 
 transcription is specific for mature oo-
cysts, the stage that marks the final step of sporozoite genera-
tion, and is subsequently down-regulated in mature salivary
gland sporozoites that are transmitted to the mammalian host
(Fig. 1 B). The orthologous genes in 
 
P. falciparum
 
 (SERA8;
PFB0325c) (17) and 
 
P. yoelii
 
 (PY02063) (18) show 54 and
81% overall amino acid sequence identity with 
 
P. berghei
 
ECP1 (PbECP1; DQ000976), respectively (Fig. 1 C). In
good agreement with our findings, the 
 
P. falciparum
 
 ortho-
logue was reported recently to be expressed specifically in
sporozoites (19) and absent from erythrocytic stages (20). All
 
Plasmodium
 
 ECP1 proteins contain a central 
 
 
 
250–amino
acid papain-family cysteine protease domain (Fig. 1 C).
Within the domain, conservation to PbECP1 is 70% and 93%
for the 
 
P. falciparum
 
 and 
 
P. yoelii
 
 orthologues, respectively. A
hallmark of papain-family cysteine proteases is the presence of
the catalytic triad with invariant cysteine, histidine, and aspar-
agine residues and the oxyanion-hole glutamine residue (8).
Presence of these residues in the ECP1 proteins indicates that
they might function as proteases (Fig. 1 D).
 
PbECP1
 
 gene disruption
 
To study the role of 
 
PbECP1
 
, we generated a loss-of-func-
tion parasite line. The endogenous 
 
ECP1
 
 copy was targeted
with an insertion plasmid (21). Homologous recombination
was expected to lead to gene disruption by generation of
two truncated nontranscribed 
 
ecp1
 
 copies (Fig. 2 A). This
strategy allows gene disruption without loss of genetic infor-
mation and is likely to minimize cis effects on neighboring
genes. The parental blood-stage population from the suc-
cessful transfection was used for cloning three independent
disruption parasite lines, termed 
 
ecp1(-)
 
. Insertion-specific
PCR analysis confirmed the correct insertion at the pre-
dicted locus (Fig. 2 B). To verify 
 
PbECP1
 
 deficiency of the
mutant parasites, we performed RT-PCR and cDNA ampli-
fication using polyA
 
 
 
 RNA from oocyst sporozoites as tem-
plates (Fig. 2 C). We also confirmed that expression of the
neighboring genes, 
 
SERA2
 
 and 
 
ORF2
 
, is not affected in the
 
ecp1(-)
 
 disruptants. We next examined the phenotype of
 
ecp1(-)
 
 parasites during the 
 
Plasmodium
 
 life cycle. As ex-
pected, 
 
ecp1
 
(-) clones were indistinguishable from WT para-
sites in development and growth of asexual and sexual 
 
Plas-
modium
 
 stages (unpublished data). Transmission to 
 
Anopheles
 
mosquitoes and oocyst development were normal when
compared with WT parasites (Table S1, available at http://
www.jem.org/cgi/content/full/jem.20050545/DC1).
We next analyzed sporozoite development by examining
oocyst morphology and comparing oocyst sporozoite num-
bers in WT and 
 
ecp1(-)
 
 parasites. No differences in genera-
tion of viable sporozoites were observed. Importantly, when
the 
 
ecp1
 
(-) sporozoites were liberated from dissected midgut
oocysts, they showed the typical short residual gliding motil-
ity of WT oocyst sporozoites in vitro (Fig. 3 A). Together,
our findings show that 
 
ECP1
 
 is dispensable for 
 
Plasmodium
 
cellular functions before sporozoite release. We conclude
that 
 
ecp1(-)
 
 parasites form viable sporozoites in numbers
comparable with WT parasites, in good agreement with our
observation that 
 
ECP1
 
 is developmentally up-regulated in
mature oocysts (Fig. 1 A).
 
ecp1(-)
 
 sporozoites fail to egress from midgut oocysts
 
Upon closer examination by phase-contrast microscopy, we
observed a peculiar arrangement of sporozoites within the
Figure 1. A stage-specific Plasmodium papain-like cysteine protease. 
(A) Expression profiling of the P. berghei SERA locus. (Top) Schematic 
diagram of the 33.5-kb PbSERA locus. Genes conserved between all Plas-
modium species are shaded gray. Rodent Plasmodium-specific genes are 
in white. ECP1, egress cysteine protease 1; PCP, papain-like cysteine pro-
tease with an active site cysteine; SERA, papain-like cysteine protease with 
an active site serine; ORF, open reading frame without homology to 
cysteine proteases. (Bottom) RT-PCRs from mixed blood-stage and mixed 
sporozoite cDNAs and genomic DNA. The merozoite- and sporozoite-specific 
transcripts, MSP1 and TRAP, were added as controls. (B) Oocyst-specific 
transcription of PbECP1. Shown is a RT-PCR analysis of PbECP1 mRNA in 
oocyst sporozoites (oo) and salivary gland sporozoites (sg). (C) Primary 
structure of Plasmodium ECP1 proteins. The putative cleavable signal 
sequences and the central papain-like cysteine protease domains are boxed 
in black and gray, respectively. Overall amino acid sequence identities of 
the P. yoelii and P. falciparum ECP1 orthologues (PY02063 and PFB0325c, 
respectively) are indicated as percentage of identical residues compared 
with the P. berghei sequence. (D) Conservation of the catalytic residues 
of the papain family within the central cysteine protease domain. The 
catalytic residues (in a shaded background and marked with an asterisk) 
are the amino-terminal cysteine and the carboxy-terminal histidine together 
with the asparagine, which orients the histidine imidazole ring. The gluta-
mine (bold and marked with ‘o’) in proximity to the catalytic cysteine 
assists in formation of the oxyanion hole. Strictly conserved amino acid 
residues are boxed in gray. 
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oocysts (Fig. 3 B). Although WT sporozoites are arranged in
a radial fashion, 
 
ecp1(-)
 
 sporozoites seemed to be organized in
circles. Intriguingly, 
 
ecp1(-)
 
 sporozoites displayed a continu-
ous circular movement around a central axis, in both clock-
wise and anticlockwise directions (Video 1, available at http:
//www.jem.org/cgi/content/full/jem.20050545/DC1). In
WT oocysts, sporozoite bending and flexing is seen on rare
occasions, presumably in preparation for egress from the oo-
cyst (unpublished data). In general, no motility can be
observed in WT oocysts (Video 2, available at http://
www.jem.org/cgi/content/full/jem.20050545/DC1). In
marked contrast, continuous circular motility was observed in
all 
 
ecp1(-)
 
 oocysts examined. This previously unrecognized
motility within midgut oocysts is likely a consequence of
a defect after completion of sporogony. This observation
prompted us to perform a detailed spatial and temporal analy-
sis of sporozoite distribution within the 
 
Anopheles
 
 mosquito
(Table I). Intriguingly, no sporozoites were detected in the
hemocoel or in the salivary glands of infected mosquitoes de-
spite efficient infection rates and high numbers of oocyst
sporozoites. Although we continued to look for salivary
Figure 2. Targeted gene disruption of P. berghei ECP1. (A) Insertion 
strategy to generate the ecp1(-) parasites. The WT ECP1 genomic locus 
(WT) is targeted with an EcoRV (E)-linearized integration plasmid (pINT) 
containing 5  and 3  truncations of the ECP1 open reading frame and the 
dhfr/ts positive selectable marker. Upon a single crossover event, the region 
of homology is duplicated, resulting in two truncated, nonexpressed ecp1 
copies in the recombinant locus (INT). Integration-specific test and WT 
primer combinations are indicated by arrows and expected fragments as 
lines. (B) Integration-specific PCR analysis. The successful integration 
event is verified by a primer combination (test) that can amplify only a 
signal from the INT locus. Absence of the WT signal from ecp1(-) parasites 
confirms the purity of the clonal population. (C) Absence of ECP1 transcripts 
in ecp1(-) parasites. cDNA from WT and ecp1(-) oocyst sporozoites were 
amplified in the presence ( ) or absence (-) of reverse transcriptase (RT). 
Note that expression of the adjacent genes, SERA2 and ORF2 (Fig. 1 A), are 
not affected in the ecp1(-) parasites.
Figure 3. ecp1(-) oocysts generate viable sporozoites. (A) ecp1(-) 
oocyst sporozoites display normal gliding locomotion. Shown are repre-
sentative immunofluorescence stainings of ecp1(-) and WT oocyst sporo-
zoites with anti-PbCSP antibodies (28) and anti-TRAP antisera (29). 
Gliding sporozoites deposit CSP in their trails. Bars, 10  m. (B) ecp1(-) 
sporozoites are confined within oocysts. Shown are interference contrast 
micrographs of WT and ecp1(-) oocysts. WT sporozoites are arranged radially 
and will eventually exit the oocyst. In contrast, ecp1(-) sporozoites do not 
escape the oocysts and orient in circles under continuous gliding locomo-
tion (Video 1). Bars, 10  m. (C) Sporozoite clusters from ecp1(-)-infected 
mosquitoes. Shown are micrographs from isolated and ground midguts. 
Free sporozoite clusters can be detected in the dissection medium indicating 
that lack of ECP1 alters the normal oocyst rupturing process. Bars, 10  m. 
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gland sporozoites throughout the life span of the mosquitoes
(
 
 
 
55 d after feeding) we failed to detect 
 
ecp1
 
(-) salivary gland
sporozoites. In WT parasites, oocyst sporozoite numbers peak
at 
 
 
 
day 14 after infection. Thereafter, sporozoites are re-
leased continuously into the hemocoel, where they can be
detected transiently (Table I). Sporozoites enter salivary
glands rapidly and actively; their final destination in the in-
vertebrate host (22). Accordingly, numbers of oocyst sporo-
zoites decline over time, whereas salivary glands remain filled
with sporozoites, rendering infected mosquitoes infectious
for life. In striking contrast, 
 
ecp1(-)
 
 oocysts do not rupture, re-
sulting in a remarkable accumulation of viable sporozoites
(Table I). Hence, the observed intraoocyst motility is likely a
consequence of the failure to egress the oocysts. We also no-
ticed that none of the persisting 
 
ecp1(-)
 
 oocysts was melanized
throughout the mosquito life span, nor were the survival rates
of the infected mosquitoes affected (unpublished data). To-
gether, our data indicate that oocysts are not breached pas-
sively by parasite growth. Instead, we propose that sporozoite
egress is an active process that requires 
 
ECP1
 
 functions.
Next, we tested whether viable motile 
 
ecp1(-)
 
 oocyst
sporozoites are infectious to the mammalian host. We in-
jected highly susceptible Sprague/Dawley rats with either
WT or 
 
ecp1(-)
 
 oocyst sporozoites (Table S2, available at http:
//www.jem.org/cgi/content/full/jem.20050545/DC1). As
expected, we achieved consistent blood-stage infections with
100,000 WT oocyst sporozoites. In striking contrast, animals
injected with even 10-fold higher doses of 
 
ecp1(-)
 
 sporozoites
remained malaria free, suggesting additional functions of
ECP1 after oocyst rupture.
Lack of ECP1 results in protected oocysts
Upon midgut dissection we also observed that ecp1(-) oo-
cysts were resistant to light mechanical stress such as gentle
grinding to free sporozoites. Occasionally we detected free-
floating oocysts that were detached from the midgut (Fig. 3
C). The oocyst capsule has a bipartite structure with the in-
ner layer being of parasite origin and the outer thick layer
deriving from the basal lamina of the mosquito midgut (23).
The inner oocyst membrane is covered by the circumsporo-
zoite protein (CSP) (24) and, hence, can serve as a marker
for oocyst permeabilization. To test if ecp1(-) oocysts are
more rigid than WT oocysts, we dissected midguts and per-
meabilized oocysts with the detergent saponin (Fig. 4 A). Al-
though all oocysts can be permeabilized with methanol and
displayed strong circumferential CSP staining, only WT oo-
cysts could be permeabilized by the natural surfactant sapo-
nin (Fig. 4 A). This finding suggests that developing Plasmo-
dium oocysts are protected by an impermeable oocyst wall
that is processed actively after sporozoite maturation. To
control for CSP levels in ecp1(-) oocyst sporozoites, we per-
formed a Western blot analysis of sporozoites dissected in the
absence or presence of the cysteine protease inhibitor E64
(Fig. 4 B; reference 25). We detected a previously unrecog-
nized additional CSP band that was specific for oocyst
sporozoites. Notably, this signal was abundant only in the
ecp1(-) mutant or when WT midguts were dissected in the
presence of E64. These findings may indicate a role of ECP1
in CSP processing. Although the substrate of ECP1 is not
known yet, CSP is a likely candidate for a direct or indirect
Table I. ecp1(-) parasites are deficient in exiting 
midgut oocysts
ecp1(-) sporozoitesa WT sporozoitesa
Daysb Oocyst Hemocoel
Salivary
gland Oocyst Hemocoel
Salivary
gland
12–14 78,200 (5) ND ND 55,500 (5) ND ND
15 82,290 (9) 0 (3) 0 (3) 41,314 (11) 627 (3) 7,220 (5)
18 111,333 (6) ND 0 (5) 36,880 (5) ND 15,440 (5)
20–28 115,750 (6) 0 (2) 0 (6) 13,045 (4) 200 (2) 10,100 (3)
30-40 108,000 (5) ND 0 (3) 6,175 (4) ND 10,633 (3)
50-55 38,500 (2) ND 0 (2) 40 (2) ND ND
aMean number of sporozoites per infected mosquito in the respective tissue. Num-
bers of independent feeding experiments are shown in parentheses.
bTime point of dissection after feeding.
Figure 4. Oocysts are protected in ecp1(-) parasites. (A) ecp1(-) 
oocysts are resistant to permeabilization by detergents (1% saponin). The 
inner oocyst membrane is stained with highly diluted anti-PbCSP antibody 
(1:1,000). Proper CSP localization is shown in methanol-fixed oocysts. 
Bars, 10  m. (B) Western blot analysis of CSP in isolated salivary gland (sg) 
or midgut (mg) sporozoites from WT or midgut sporozoites from ecp1(-) 
parasites. In addition to the typical CSP doublet (marked with asterisks), an 
intermediate midgut-specific band can be detected in the ecp1(-) mutant 
and in WT sporozoites that were isolated in the presence of 100  M 
cysteine protease inhibitor E64.JEM VOL. 202, July 18, 2005 229
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downstream proteolytic processing event, particularly be-
cause it seems to be one of the dominant parasite-derived
components lining the inner side of the oocysts (24).
Collectively, our data suggest that ECP1 plays a central
role in the egress of the sporozoites from midgut oocysts.
Lack of ECP1 proteolytic activity blocked the life cycle of
malaria parasites inside the mosquito vector at the oocyst
stage. Therefore, inhibition of oocyst rupture provides an
additional target for transmission-blocking strategies. Oo-
cysts stand out in the Plasmodium life cycle, because they rep-
resent the longest developmental phase and the only replica-
tive phase of the malaria parasites that does not need host
cells for its expansion. Despite their importance, oocysts re-
main the least-characterized mosquito stage of Plasmodium.
Purification of protected ecp1(-) oocysts may provide a rare
resource for a detailed analysis of the molecular repertoire of
mature oocysts. Our study may pave the way for the identi-
fication of similar egress cysteine proteases that drive mero-
zoite release from liver-stage and blood-stage schizonts by
targeted gene disruption. This possibility is supported by the
inhibitory effect of cysteine protease inhibitors on merozoite
egress from host erythrocytes (5, 6). Identifying an essential
function of cysteine proteases, such as the one of ECP1 for
sporozoite egress, is fundamental for drug-target validation
and rational design of inhibitors.
MATERIALS AND METHODS
Experimental animals. Animals were from Charles River Laboratories.
All animal work was conducted in accordance with European regulations
and approved by the state authorities (Regierungspräsidium Karlsruhe).
Generation of the ecp1(-) parasite line. For targeted disruption of
ECP1, an integration vector was generated by amplification of a PCR
fragment using P. berghei genomic DNA as template and primers
ECP1for (5 -GGACTAGTGAGCATATAGAAAGCCATATTCAAC-
3 ; SpeI site is underlined) and ECP1rev (5 -TCCCCGCGGGCACC-
TTGCTCAATTATGTAATCTTTTAAG-3 ; SacII site is underlined).
Cloning into the P. berghei transfection vector (21) resulted in plasmid
pAA05. The targeting plasmid was linearized with EcoRV, and parasite
transfection, positive selection, and parasite cloning were performed as
described previously (21). Integration-specific PCR amplification of the
ecp1(-) locus was generated using specific primer combinations. We ob-
tained three independent ecp1(-) clonal parasite populations that were
phenotypically identical. Detailed analysis was performed with one rep-
resentative clone.
Transcript detection. For RT-PCR analysis, we isolated poly (A )
RNA from 5   105 WT salivary gland sporozoites and 106 WT and ecp1(-)
oocyst sporozoites, respectively, using oligo dT-columns (Invitrogen). For
cDNA synthesis and amplification, we performed a two-step PCR using
random decamer primers (Ambion) and subsequent standard PCR reac-
tions, using gene-specific primers.
Phenotypical analysis during the Plasmodium life cycle. Blood-stage
development was analyzed in vivo in asynchronous infections using Naval
Medical Research Institute mice. Gametocyte differentiation and exflagella-
tion of microgametes were detected in mice before mosquito feedings.
Sporozoite populations were separated and analyzed as described previously
(26, 27). Adherent sporozoites were incubated with a mAb against P. berghei
circumsporozoite protein (PbCSP) (28) and a polyclonal anti–P. berghei
thrombospondin-related anonymous protein (TRAP) antiserum (29).
Bound antibodies were detected using Alexa Fluor 546–conjugated anti–
mouse antibodies and Alexa Fluor 488–conjugated anti–rabbit antibodies,
respectively (Molecular Probes).
In vivo infectivity of sporozoites. For determination of the infectivity
of oocyst sporozoites, infected midguts were dissected at days 15–17 after
feeding. Sporozoites were liberated and injected i.v. at the numbers indi-
cated into young Sprague/Dawley rats. Patency was checked daily by Gi-
emsa-stained blood smears.
Oocyst immunofluorescence. For the analysis of CSP localization in
the oocysts, infected midguts were fixed in 2% formaldehyde/0.2% glutaral-
dehyde, permeabilized with 1% saponin in PBS/1% FCS or with ice-cold
methanol and incubated with primary anti-PbCSP (1:1,000; reference 28).
At the high-antibody dilution, internal sporozoites are not visualized.
Bound antibodies were detected using Alexa Fluor 488–conjugated anti–
mouse antibodies.
Western blot analysis. For detection of CSP levels in WT and ecp1(-)
oocysts, we dissected midguts of infected mosquitoes at day 15 after infec-
tion. Infected midguts were isolated, ground, and pelleted in the presence
or absence of freshly prepared 100- M E64 (Sigma-Aldrich; reference 5).
Total oocyst lysates equivalent to 100,000 oocyst sporozoites and, as a con-
trol, 100,000 WT salivary gland sporozoites were separated on a 10% SDS
PAGE and transferred to a nitrocellulose membrane. CSP was detected
with primary anti-PbCSP (1:8,000; reference 28). Bound antibodies were
detected using horseradish peroxidase–conjugated anti-mouse antibodies
(Sigma-Aldrich).
Online supplemental material. Table S1 shows that oocyst develop-
ment of ecp1(-) parasites is not affected compared with WT parasites. Table
S2 shows that ecp1(-) oocyst sporozoites are noninfectious to the mammalian
host. Video 1 shows real-time live-imaging of ecp1(-) oocysts. ecp1(-) sporo-
zoites lack the capacity to egress oocysts and instead display continuous cir-
cular motility. Video 2 shows the corresponding WT oocysts with no de-
tectable internal motility. Online supplemental material is available at
http://www.jem.org/cgi/content/full/jem.20050545/DC1.
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